Listed

Angiodynamics Inc: Form 10-Q for the period ended Nov 30, 2019

Filed with the SEC on Jan 8, 2020 and accepted by EDGAR at Jan 8, 2020, 14:39 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-11-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-09-01 to 2019-11-30$70.0mus-gaap:Revenues
Revenue6 months2019-06-01 to 2019-11-30$136.0mus-gaap:Revenues
Cost of revenue3 months2019-09-01 to 2019-11-30$28.5mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2019-06-01 to 2019-11-30$56.3mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2019-09-01 to 2019-11-30$41.5mus-gaap:GrossProfit
Gross profit6 months2019-06-01 to 2019-11-30$79.8mus-gaap:GrossProfit
Research and development3 months2019-09-01 to 2019-11-30$7.8mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2019-06-01 to 2019-11-30$14.1mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2019-09-01 to 2019-11-30−$3.4mus-gaap:OperatingIncomeLoss
Operating income6 months2019-06-01 to 2019-11-30−$4.3mus-gaap:OperatingIncomeLoss
Interest expense3 months2019-09-01 to 2019-11-30$41.0kus-gaap:InterestExpense
Interest expense6 months2019-06-01 to 2019-11-30$506.0kus-gaap:InterestExpense
Income tax3 months2019-09-01 to 2019-11-30−$566.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2019-06-01 to 2019-11-30−$682.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-09-01 to 2019-11-30−$2.7mus-gaap:NetIncomeLoss
Net income6 months2019-06-01 to 2019-11-30−$4.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2019-09-01 to 2019-11-30−$0.07us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2019-06-01 to 2019-11-30−$0.11us-gaap:EarningsPerShareDiluted
Basic EPS3 months2019-09-01 to 2019-11-30−$0.07us-gaap:EarningsPerShareBasic
Basic EPS6 months2019-06-01 to 2019-11-30−$0.11us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2019-09-01 to 2019-11-3037,992,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2019-06-01 to 2019-11-3037,887,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2019-06-01 to 2019-11-30−$597.0kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2019-06-01 to 2019-11-30$4.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2019-11-30$41.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-11-30$132.0mus-gaap:AssetsCurrent
Total assetsAt period end2019-11-30$724.9mus-gaap:Assets
Current liabilitiesAt period end2019-11-30$57.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-11-30$111.1mus-gaap:Liabilities
Current portion of debtAt period end2019-11-30$0us-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2019-11-30$613.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001275187-20-000005. Last ingested by Listed: Nov 4, 2026, 20:24 ET. Listed shows no prices and gives no investment advice.